UNIQURE N.V. EO -,05/ NL0010696654 /
| 2024-04-16 8:10:09 AM | Chg. +0.0220 | Volume | Bid8:10:11 AM | Ask8:10:11 AM | High | Low |
|---|---|---|---|---|---|---|
| 4.2620EUR | +0.52% | 0 Turnover: 0.0000 |
4.2620Bid Size: 1,000 | 4.6620Ask Size: 900 | 4.2620 | 4.2620 |
GlobeNewswire
01-03
US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire
2023-12-19
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
2023-11-29
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
2023-11-15
Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire
2023-11-07
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
GlobeNewswire
2023-10-24
uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Mee...
GlobeNewswire
2023-10-05
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of M...
GlobeNewswire
2023-09-05
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for...
GlobeNewswire
2022-03-21
uniQure Announces Completion of Patient Enrollment in the First Two Cohorts of its Phase I/II Clinic...
GlobeNewswire
2022-03-02
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
GlobeNewswire
2022-02-25
uniQure Announces 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire
2022-02-07
uniQure Announces Dosing of First Patients in European Open-Label Clinical Trial of AMT-130 Gene The...
GlobeNewswire
2021-12-16
uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene The...
GlobeNewswire
2021-12-09
uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene D...
GlobeNewswire
2021-11-10
Spero Therapeutics Announces Third Quarter 2021 Operating Results and Provides Business Update
GlobeNewswire
2021-11-02
uniQure Announces Latest Positive Recommendation from Data Safety Monitoring Board in Phase I/II Cli...
GlobeNewswire
2021-10-25
uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire
2021-10-21
uniQure Announces the Appointment of Rachelle Jacques to its Board of Directors
GlobeNewswire
2021-10-19
uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Thera...
GlobeNewswire
2021-09-30
uniQure to Participate in Multiple Upcoming Industry Conferences in October
